Bris­tol My­ers gets reg­u­la­to­ry clear­ance to close Mi­rati deal as FTC in­creas­es pres­sure on phar­ma M&A

Bris­tol My­ers Squibb has the go-ahead from an­titrust reg­u­la­tors to com­plete its $4.8 bil­lion takeover of Mi­rati.

In­creased FTC scruti­ny has put large phar­ma merg­ers …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER